In:
Journal of Cellular and Molecular Medicine, Wiley, Vol. 27, No. 7 ( 2023-04), p. 950-961
Abstract:
Tax1 binding protein 3 (Tax1bp3) is a PDZ domain‐containing protein that is overexpressed in cancer. Previous studies recognized Tax1bp3 as an inhibitor of β‐catenin. Till now it is not known whether Tax1bp3 regulates osteogenic and adipogenic differentiation of mesenchymal progenitor cells. In the current study, the data showed that Tax1bp3 was expressed in bone and was increased in the progenitor cells when induced toward osteoblast and adipocyte differentiation. The overexpression of Tax1bp3 in the progenitor cells inhibited osteogenic differentiation and conversely stimulated adipogenic differentiation, and the knockdown of Tax1bp3 affected the differentiation of the progenitor cells oppositely. Ex vivo experiments using the primary calvarial osteoblasts from osteoblast‐specific Tax1bp3 knock‐in mice also demonstrated the anti‐osteogenic and pro‐adipogenic function of Tax1bp3. Mechanistic investigations revealed that Tax1bp3 inhibited the activation of canonical Wnt/β‐catenin and bone morphogenetic proteins (BMPs)/Smads signalling pathways. Taken together, the current study has provided evidences demonstrating that Tax1bp3 inactivates Wnt/β‐catenin and BMPs/Smads signalling pathways and reciprocally regulates osteogenic and adipogenic differentiation from mesenchymal progenitor cells. The inactivation of Wnt/β‐catenin signalling may be involved in the reciprocal role of Tax1bp3.
Type of Medium:
Online Resource
ISSN:
1582-1838
,
1582-4934
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
2076114-4
